Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Ruberg

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
JACC. Advances|June 18, 2026
Diagnostic Performance of the Mayo ATTR-CM Score in Diverse Populations: Comparison With the AMY ScorePatricia Carey, Nelson I Barrera, Gregorio Tersalvi, et al.
Journal of Cardiac Failure|May 13, 2026
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM TrialAmrut V Ambardekar, Nitasha Sarswat, Richard Wright, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 13, 2023
Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 casesNicholas Chan, Andrew J Einstein, Jan M Griffin, et al.
Journal of the American College of Cardiology|October 27, 2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CMAhmad Masri, Daniel P Judge, Frederick L Ruberg, et al.
BMC Family Practice|September 24, 2020
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitionerMorie Gertz, David Adams, Yukio Ando, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 15, 2026
Design and Rationale of the REVEAL PET Study: A Study of <sup>124</sup>I-evuzamitide to Diagnose Cardiac AmyloidosisSharmila Dorbala, Mathew S Maurer, Sarah A M Cuddy, et al.
JAMA Cardiology|September 10, 2025
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart FailureFrederick L Ruberg, Sergio Teruya, Stephen Helmke, et al.
Circulation|September 8, 2023
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection FractionJesse D Cochran, Yoshimitsu Yura, Mark C Thel, et al.
Orphanet Journal of Rare Diseases|May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableThomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
JAMA|January 25, 2022
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021Matthew E Oster, David K Shay, John R Su, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
JACC. Advances|June 18, 2026
Diagnostic Performance of the Mayo ATTR-CM Score in Diverse Populations: Comparison With the AMY ScorePatricia Carey, Nelson I Barrera, Gregorio Tersalvi, et al.
Journal of Cardiac Failure|May 13, 2026
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM TrialAmrut V Ambardekar, Nitasha Sarswat, Richard Wright, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 13, 2023
Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 casesNicholas Chan, Andrew J Einstein, Jan M Griffin, et al.
Journal of the American College of Cardiology|October 27, 2025
Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CMAhmad Masri, Daniel P Judge, Frederick L Ruberg, et al.
BMC Family Practice|September 24, 2020
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitionerMorie Gertz, David Adams, Yukio Ando, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 15, 2026
Design and Rationale of the REVEAL PET Study: A Study of <sup>124</sup>I-evuzamitide to Diagnose Cardiac AmyloidosisSharmila Dorbala, Mathew S Maurer, Sarah A M Cuddy, et al.
JAMA Cardiology|September 10, 2025
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart FailureFrederick L Ruberg, Sergio Teruya, Stephen Helmke, et al.
Circulation|September 8, 2023
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection FractionJesse D Cochran, Yoshimitsu Yura, Mark C Thel, et al.
Orphanet Journal of Rare Diseases|May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableThomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
JAMA|January 25, 2022
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021Matthew E Oster, David K Shay, John R Su, et al.
Pageof 11